<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - CRXX</title>
<description>International Business News - CRXX</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>Synavive data sends CombinatoRx to all-time lows</title>
  <description>Shares of CombinatoRx Inc. crashed to an all-time low Monday after the biotech company said its lead drug candidate missed its main goal in clinical trial.</description>
    <link>http://www.ibtimes.com/articles/20081006/synavive-data-sends-combinatorx-to-all-time-lows.htm</link> 
  <pubDate>Mon, 06 Oct 2008 20:17:07 EDT</pubDate>
  </item>


  <item>
  <title>CombinatoRx plunges on Synavive trial failure</title>
  <description>The drug candidate Synavive missed its main goal in a clinical trial, developer CombinatoRx Inc. said Monday, as the drug did not significantly improve symptoms of osteoarthritis of the knee compared with a placebo.</description>
    <link>http://www.ibtimes.com/articles/20081006/combinatorx-plunges-on-synavive-trial-failure.htm</link> 
  <pubDate>Mon, 06 Oct 2008 10:04:39 EDT</pubDate>
  </item>


  <item>
  <title>CombinatoRx 2Q loss grows on higher research costs</title>
  <description>Biotech drug developer CombinatoRx Inc. said Wednesday its second-quarter loss widened as the company spent more money to develop its drug candidates Synavive and CRx-401 and revenue decreased.</description>
    <link>http://www.ibtimes.com/articles/20080806/combinatorx-2q-loss-grows-on-higher-research-costs.htm</link> 
  <pubDate>Wed, 06 Aug 2008 10:33:56 EDT</pubDate>
  </item>


</channel>
</rss>